Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.89B | 13.46B | 13.31B | 8.82B | 10.71B | Gross Profit |
3.70B | 3.29B | 2.78B | 2.04B | 2.25B | EBIT |
1.56B | 1.39B | 985.79M | 386.31M | 620.99M | EBITDA |
1.84B | 1.67B | 1.29B | 655.95M | 881.47M | Net Income Common Stockholders |
1.22B | 1.12B | 799.73M | 373.49M | 545.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.68B | 2.97B | 4.65B | 4.83B | 1.90B | Total Assets |
15.86B | 16.63B | 17.29B | 13.97B | 11.13B | Total Debt |
1.07B | 1.06B | 1.11B | 1.16B | 1.21B | Net Debt |
-2.61B | -1.91B | -3.55B | -3.67B | -686.01M | Total Liabilities |
6.42B | 8.55B | 10.61B | 8.25B | 5.62B | Stockholders Equity |
9.44B | 8.07B | 6.68B | 5.72B | 5.52B |
Cash Flow | Free Cash Flow | |||
962.54M | -1.40B | -164.21M | 3.00B | 1.03B | Operating Cash Flow |
1.01B | -1.37B | -91.12M | 3.03B | 1.07B | Investing Cash Flow |
-109.92M | -86.55M | 71.26M | 26.77M | -88.91M | Financing Cash Flow |
-186.23M | -236.15M | -157.94M | -125.72M | -327.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥5.12B | 5.85 | 3.18% | 0.55% | 21.35% | ||
79 Outperform | ¥4.98B | 7.12 | 2.79% | 0.58% | -16.60% | ||
79 Outperform | ¥5.26B | 11.60 | 2.40% | 11.35% | 51.98% | ||
74 Outperform | ¥3.92B | 3.21 | 8.57% | -4.23% | 9.27% | ||
69 Neutral | ¥4.01B | 38.37 | ― | -2.13% | -86.64% | ||
66 Neutral | $4.46B | 12.15 | 5.40% | 4.71% | 4.16% | -11.97% | |
64 Neutral | ¥3.34B | 27.10 | 1.36% | 32.99% | -61.72% |